reference/16713529

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/16713529

Outgoing Links

Predicate	Object
contentType	Journal Article\|Randomized Controlled Trial
endingPage	457
issn	1098-6596 0066-4804
issueIdentifier	2
pageRange	450-457
publicationName	Antimicrobial Agents and Chemotherapy
startingPage	450
bibliographicCitation	Jacobson JM, Kuritzkes DR, Godofsky E, DeJesus E, Larson JA, Weinheimer SP, Lewis ST. Safety, pharmacokinetics, and antiretroviral activity of multiple doses of ibalizumab (formerly TNX-355), an anti-CD4 monoclonal antibody, in human immunodeficiency virus type 1-infected adults. Antimicrob Agents Chemother. 2009 Feb;53(2):450–7. PMID: 19015347; PMCID: PMC2630626.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5c9d990c5cd06a6ffd0a13399f781d7b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ef92f96fb71b4fd322e8df2d3251a08d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ebd12884cba2dd583dc45efc5b66a3ca http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f8a6be52c64f62b1d70df9fb058d7943 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bb2a99a1dc27f7ffe141dad2a58e4aec http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cd0a3950b61b974d89fe903af31f64cf http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9575ac72fc4c9a01da1c28946cbfa4c2
date	200902
identifier	https://pubmed.ncbi.nlm.nih.gov/PMC2630626 https://doi.org/10.1128/aac.00942-08 https://pubmed.ncbi.nlm.nih.gov/19015347
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/686 https://portal.issn.org/resource/ISSN/0066-4804 https://portal.issn.org/resource/ISSN/1098-6596
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Safety, Pharmacokinetics, and Antiretroviral Activity of Multiple Doses of Ibalizumab (formerly TNX-355), an Anti-CD4 Monoclonal Antibody, in Human Immunodeficiency Virus Type 1-Infected Adults
discusses	http://id.nlm.nih.gov/mesh/M0024085 http://id.nlm.nih.gov/mesh/M0028839 http://id.nlm.nih.gov/mesh/M0019224 http://id.nlm.nih.gov/mesh/M0274523 http://id.nlm.nih.gov/mesh/M0001357 http://id.nlm.nih.gov/mesh/M0460791 http://id.nlm.nih.gov/mesh/M0016224 http://id.nlm.nih.gov/mesh/M0024088
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D015658Q000188 http://id.nlm.nih.gov/mesh/D015497 http://id.nlm.nih.gov/mesh/D019380Q000627 http://id.nlm.nih.gov/mesh/D000911Q000009 http://id.nlm.nih.gov/mesh/D000911Q000627 http://id.nlm.nih.gov/mesh/D019380Q000009
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D019380Q000493 http://id.nlm.nih.gov/mesh/D015496Q000187 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D024882 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D015704Q000276 http://id.nlm.nih.gov/mesh/D007111 http://id.nlm.nih.gov/mesh/D019540 http://id.nlm.nih.gov/mesh/D014779Q000187 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D000911Q000493 http://id.nlm.nih.gov/mesh/D015700Q000494 http://id.nlm.nih.gov/mesh/D055815 http://id.nlm.nih.gov/mesh/D015658Q000821 http://id.nlm.nih.gov/mesh/D010446Q000494 http://id.nlm.nih.gov/mesh/D008214Q000187 http://id.nlm.nih.gov/mesh/D006207 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D000077560 http://id.nlm.nih.gov/mesh/D005500 http://id.nlm.nih.gov/mesh/D012367Q000097
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_aaae4c7bac4f7c975bd722cfc5c8a6d7 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_f3cf85477bbb4417d5e1bac0b803ec08 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_68000b5f90a1d5b5b1a93dbb8aa92d3e http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16130199

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135754805

Total number of triples: 68.